IMP sponsor Boehringer Ingelheim has constructed a new flagship for the Vienna Biocenter, the Life Science cluster in Vienna, with an investment of 52 million euros. Representatives from politics, industry and science celebrated the opening.
The Research Institute of Molecular Pathology (IMP)
The IMP is a basic biomedical research institute located at the Campus Vienna Biocenter. Our scientists are passionately committed to scientific discovery, seeking to unlock some of life’s fundamental mysteries. The IMP is supported by Boehringer Ingelheim and through research grants from national and international funding agencies.
Vienna is one of the cultural capitals of Europe and has one of the highest standards of living in the world. The Vienna of today is a modern, international metropolis in the heart of Central Europe, a city with a quality lifestyle and an embraceable joy for living.
The Vienna Biocenter in the third district of Vienna has established itself as the premier location for life sciences in Central Europe and is a world-leading international bio-medical research center.